Published in J Neurol on October 13, 2016
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet (2003) 3.55
Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet (2004) 2.50
Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet (2006) 2.00
Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy. Neurology (2014) 1.80
Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet (2002) 1.64
Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat (2009) 1.57
The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry (2011) 1.46
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain (2010) 1.45
Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases. Ann Neurol (2007) 1.28
REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction. Hum Mutat (2011) 1.26
Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. Ann Neurol (2005) 1.25
Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain (2008) 1.22
Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain (2008) 1.21
New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics (2008) 1.17
Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am J Hum Genet (2012) 1.16
The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain (2004) 1.13
Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain (2002) 1.09
Familial spastic paraplegia with amyotrophy of the hands. Ann Hum Genet (1966) 1.08
Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci (2007) 1.04
Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging (2011) 0.96
Clinical and histopathological study of Charcot-Marie-Tooth neuropathy with a novel S90W mutation in BSCL2. Neurogenetics (2012) 0.93
Phenotypic and genotypic heterogeneity in hereditary motor neuronopathy type V: a clinical, electrophysiological and genetic study. Brain (2000) 0.92
BSCL2 mutations in two Dutch families with overlapping Silver syndrome-distal hereditary motor neuropathy. Neuromuscul Disord (2006) 0.89
The first Italian family with evidence of pyramidal impairment as phenotypic manifestation of Silver syndrome BSCL2 gene mutation. Neurol Sci (2008) 0.85
Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation. Muscle Nerve (2013) 0.85
Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: historical background for the first International Conference. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 0.84
Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes. Hum Genet (2003) 0.84
A novel 16p locus associated with BSCL2 hereditary motor neuronopathy: a genetic modifier? Neurogenetics (2009) 0.83
Identification of de novo BSCL2 Ser90Leu mutation in a Korean family with Silver syndrome and distal hereditary motor neuropathy. Muscle Nerve (2007) 0.82
Seipin S90L mutation in an Italian family with CMT2/dHMN and pyramidal signs. Muscle Nerve (2010) 0.80
Clinical and electrophysiological features in a French family presenting with seipinopathy. Neuromuscul Disord (2014) 0.77
N88S mutation in the BSCL2 gene in a Serbian family with distal hereditary motor neuropathy type V or Silver syndrome. J Neurol Sci (2010) 0.77
BSCL2 S90L mutation in a Chinese family with Silver syndrome with a review of the literature. J Clin Neurosci (2014) 0.76
BSCL2 N88S mutation in a Portuguese patient with the Silver syndrome. Muscle Nerve (2015) 0.76
Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry (2015) 1.56
Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy. PLoS One (2015) 1.39
Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6. Eur J Hum Genet (2013) 0.85
Adult-Onset Niemann-Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult. Front Neurol (2017) 0.84
Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Cephalalgia (2016) 0.78
Gait initiation in children with Rett syndrome. PLoS One (2014) 0.77
A semi-automated method to assess intraepidermal nerve fibre density in human skin biopsies. Histopathology (2015) 0.76
Low-energy trauma-induced intercondylar femoral fracture. Clin Cases Miner Bone Metab (2016) 0.75
Directional leads for deep brain stimulation: Opportunities and challenges. Mov Disord (2017) 0.75
Stimulation of the mesencephalic locomotor region for gait recovery after stroke. Ann Neurol (2017) 0.75
Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: long-term data of the SIGNS study. Eur J Haematol (2017) 0.75
Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type. Amyloid (2021) 0.75